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Background: It is important to ensure that the timely administration of appropriate
antimicrobial decolonization therapy occurs when patients are identified as meticillin-
resistant Staphylococcus aureus (MRSA)-colonized. Computerized Provider Order Entry
(CPOE) with embedded Clinical Decision Support (CDS) may help to facilitate this.
Aim: To investigate changes in the average time from patient admission to administration
of MRSA decolonization antimicrobial therapy in the context of various national and local
infection control interventions, including the use of CPOE.
Methods: Data concerning the time of admission and of administration of patients’ first
MRSA decolonization antimicrobials were extracted from a locally developed CPOE system
(Prescribing Investigation and Communications System: PICS) which was introduced at a
large university teaching hospital in the UK in 1998. Data were extracted retrospectively
from January 2006 to March 2012.
Findings: A variety of relevant local and national interventions occurred from 2006 to
2012. Notably, the automatic charting of MRSA decolonization antimicrobial therapy was
introduced in December 2007. There was a significant decline of 15.0% per year (95%
confidence interval: 11.1e18.7%; P < 0.001) in the time taken from admission to admin-
istration of MRSA decolonization antimicrobial therapy during the study period.
Conclusions: Numerous factors may have contributed to the observed reductions in the time
from admission to administration of MRSA decolonization antimicrobials, including the
implementation of specific features within a CPOE system. By rapidly attending to positive
MRSA colonizations there is decreased potential for MRSA to spread,whichmay help to reduce
the prevalence of MRSA colonizations within hospitals and improve patient outcomes.
ª 2014 The Authors. Published by Elsevier Ltd on behalf of the Healthcare Infection
Society. All rights reserved.CC BY license (http://
ucation Centre, Univer-
st, Queen Elizabeth Hos-
n, Birmingham B15 2WB,
371 4204.
(J.J. Coleman).
uthors. Published by ElsevierIntroduction
Healthcare-associated infections (HCAIs) such as those due
to meticillin-resistant Staphylococcus aureus (MRSA) are
problematic in hospitals worldwide.1 MRSA eradication is a
priority in UK hospitals and reductions in the prevalence ofLtd on behalf of the Healthcare Infection Society. All rights reserved.
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attributed to a number of factors, including routine screening
for MRSA colonization (i.e. asymptomatic carriers),
transmission-based precautions (e.g. use of antibacterial
handwash), antimicrobial stewardship (e.g. prescribing anti-
biotics only when necessary to prevent new antibiotic resis-
tance) and patient isolation.2e6 It is important to promote the
timely detection of MRSA colonization in patients and admin-
istration of appropriate antimicrobial drugs (e.g. mupirocin,
chlorhexidine) for decolonization, which may help to reduce
the opportunity for MRSA to spread within hospitals.
The use of Computerized Provider Order Entry (CPOE) sys-
tems with embedded Clinical Decision Support (CDS) may help
to ensure that appropriate treatment responses rapidly follow
the detection of HCAIs such as MRSA, by improving workflow
and efficiency. Following the implementation of a CPOE sys-
tem, Chapman et al. observed a non-significant reduction from
131 to 125min in the time from admission to administration of
antibiotics in a neonatal intensive care unit (ICU).7 Further-
more, Panosh et al. found a significant reduction from 3.18 to
2.00 h in the time from ordering to administration of antimi-
crobial drugs after CPOE had been introduced into their uni-
versity teaching hospital.8 Other studies have suggested that
CPOE has helped to decrease both staff work time and rates of
MRSA in hospitals following the implementation of the auto-
matic ordering of MRSA surveillance cultures by the CPOE sys-
tem and improved rates of patient isolation following the
provision of electronic alerts upon the identification of
multidrug-resistant bacteria.6,9 CPOE systems with embedded
CDS may eliminate the need to manually complete certain
stages in the process from patient admission to monitoring for
and treating antimicrobial infection. In the present study, we
investigated the time taken from patient admission to admin-
istration of MRSA decolonization antimicrobial therapy in theFigure 1. Screen shot example of patientcontext of various local and national policy changes and in
relation to relevant changes to our CPOE system.
Methods
Setting and study population
This work was carried out in a large National Health Service
(NHS) hospital in the UK. The hospital has prioritized infection
prevention and control, and specifically MRSA decoloniza-
tion.10 This has resulted in strict MRSA-screening procedures
and prompt treatment of positive cases.11 The hospital uses a
locally developed CPOE system e Prescribing Investigation and
Communications System (PICS) e which is embedded with
CDS. PICS was co-designed by clinical and technical experts
within the hospital and is in use throughout all (w1200)
inpatient beds and for all prescribing, except for some
chemotherapy regimens. PICS was first installed on the renal
unit in 1998.12 By 2006, more than 50% of the beds in the
hospital were live on PICS and the roll-out was fully completed
in 2008. PICS now covers all general and specialist medical and
surgical specialties in the hospital (excluding obstetric,
paediatric, and mental health patients, which are treated in
other organizations). Importantly, for the purpose of this
study, upon the receipt of a new positive MRSA laboratory
result from any sample tested by the microbiology depart-
ment, PICS alerts users to the presence of MRSA. This is
notified by a pop-up alert to clinical staff and then continu-
ously represented by a visual indicator within the individual
patient record, an example of which is displayed in Figure 1.
Furthermore, the system records the date and time at which
each laboratory sample is identified as MRSA positive, and the
time at which associated decolonizing antimicrobial drugs are
prescribed and administered.record when patient is MRSA positive.
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MRSA response capabilities were first introduced into PICS in
2005. Since then, governmental guidelines and hospital policies
have impacted upon the nature of MRSA screening and decolo-
nization processes within the hospital (e.g. the timings of
screenings throughout inpatient spells), infectionprevention and
control protocols (e.g. mandatory handwashing), and features
withinPICS relating toMRSA.13e18 Forexample, inNovember2007
it became possible for PICS to automatically populate the record
for MRSA antimicrobial decolonization therapy following the
identification of positive MRSA swabs. Whereas the majority of
prescriptions will be configured automatically by the system, it
remains possible for doctors to manually prescribe MRSA-
decolonizing antimicrobials prior to the receipt of a positive
laboratory result. Other factors, such as the use of the poly-
merase chain reaction (PCR) approach to detect MRSA betweenTable I
Summary of national (C) and local (B) interventions related to MRSA
Date
June 2005 C Saving Lives: a delivery programme to r
launched to raise awareness of MRSA and
treatment and prevention.13
September 2005 B Microbiology department reports positiv
B Patient MRSA status becomes visible on
positive, mupirocin sensitive; previously
B Clinical Decision Support (CDS) proposes
generated for doctors to authorize the p
B Upon authorization, nurses are alerted t
October 2006 C Health Act 2006: DoH requirement for ho
June 2007 C DoH recommends MRSA screening for pre
dialysis patients, previously positive pat
patients, and patients admitted from hig
November 2007 B New weekly drug administration therapy
December 2007 B CDS automatically populates MRSA decol
B A function is available to override autom
B If ‘no longer positive’ flag received via the
the end of 7-day cycle.
January 2008 B Changes made to patient admission scre
hospital in past 6 months, or admitted fro
prescribed MRSA decolonization therapy
treatment protocol is automatically star
B PCR detection of MRSA screens from acu
StaphSR; BD Diagnostics, Oxford, UK) run
Bank Holidays. Results released into PIC
B Implementation of Kiestra laboratory au
July 2008 C Health & Social Care Act 2008.16
March 2009 B Long-stay swab implemented (swab aler
April 2009 BAll patients swabbed upon admission.
June 2009 C National Audit Office Publication: Reduc
April 2010 C Update to Health and Social Care Act 200
systems must be in place to detect, prev
relevant premises, equipment and mate
December 2010 B Implementation of chromogenic agar for
overnight incubation.
January 2011 B PCR detection of MRSA screens from acu
2012 No relevant interventions.
MRSA, meticillin-resistant Staphylococcus aureus; PICS, Prescribing Inve
HCAI, healthcare-associated infection; UHB, University Hospitals Birmin
a Some differences apply in the critical care (intensive therapy unit) dJanuary 2008 and January 2011, or the implementation of chro-
mogenic agar forMRSA screening to allow for faster identification
of MRSA colonization, may also have impacted upon the timeli-
ness of the administration of MRSA antimicrobials. A summary of
relevant local and national interventions is presented in Table I.
Data capture
This study used data from January 2006 to March 2012
concerning the dates and times that patients (i) were first
admitted to hospital, and (ii) were first administered MRSA
antimicrobial therapy. Data were collected retrospectively.
From 2006 onwards large units within the hospital, such as
General Medicine, started using PICS. We therefore extracted
data from 2006 onwards as after this point the majority of data
could be captured and reported. For the purpose of this study
we analysed data relating to the first identified case of MRSAdecolonizationa
Intervention
educe healthcare associated infection including MRSA: series
evidence-based guidelines for best practice regarding
e MRSA results to PICS.
PICS via coloured symbols (positive, mupirocin resistant;
positive).
prescription of MRSA decolonization therapy and an alert is
rescription.
o administer drugs.
spitals to have systems in place to minimize HCAIs.14
operative patients, emergency admissions to critical care,
ients, elective surgical patients, oncology/chemotherapy
h-risk settings.15
regimen (‘5 days on, 2 days off’) updated in PICS.
onization therapy except in the presence of drug allergies.
atic prescribing if clinically appropriate.
patient record, the rule ends the prescription of MRSA drugs at
ens to identify MRSA risk (previous admission to UHB or other
m residential/care home) and these patients are automatically
. In critical care, all patients are screened for MRSA and the
ted.
te surgical unit started. MRSA PCRs (nasal swabs: GeneOhm
twice daily, MondayeFriday or morning only on Saturdays and
S at about 12:00 and 16:00.
tomation system to process more MRSA screens more rapidly.
t on PICS every 28 days unless on MRSA protocol).
ing HCAIs in hospitals in England.17
8: patients and staff must be protected against HCAIs. Suitable
ent and control HCAIs, treat those infected and maintain
rials.18
MRSA screening. Allows presumptive MRSA to be identified after
te surgical unit stopped.
stigation and Communications System; DoH, Department of Health;
gham; PCR, polymerase chain reaction.
epartment only.
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only (growth of MRSA from screening swabs or PCR detection
from screens). This was due to the system automatically
prompting for (before December 2007) or prescribing (from
December 2007) MRSA-decolonizing antimicrobials on any
subsequent admissions for those patients who were colonized
during their first admission. As a result, the process from
admission to administration of MRSA decolonization antimi-
crobial therapy is different for patients during subsequent
inpatient spells. There were too few cases of readmission data
to perform a comparative analysis of these data in this study.
Furthermore, we excluded MRSA bacteraemia cases. This was
due to the limited number of bacteraemia cases and differ-
ences in the time taken to administer MRSA decolonization
antimicrobial therapy as a result of differences in the time
needed for colonization and bacteraemia samples to be
cultured in the laboratory. This meant that it was not possible
to combine the respective cases for analysis.
Analysis
Due to the amount of skew in the distribution, the time from
admission to administration of MRSA decolonization therapy
was log10-transformed prior to analysis. The resulting
variable was then set as the dependent variable in a regression
model. For each admission, the time, in years, from the
commencement of the study was calculated for each patient
and included as a continuous covariate in this model.
The coefficient from the regression model could then be
interpreted as the yearly change in the average log10-trans-
formed time from admission to administration of MRSA-
decolonization therapy. Hence, the anti-log10 of this value
would represent the multiplicative yearly change in the time
from admission to administration of MRSA-decolonization9
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Figure 2. Geometric mean time from admission to administration
colonization swabs.therapy. This was then further converted to a percentage
change for ease of interpretation.
All analyses were performed using IBM SPSS 19 (IBM Corp.,
Armonk, NY, USA), with P < 0.05 considered statistically
significant.
Results
Data were obtained for a total of 1403 cases. For 1316 (94%)
of these cases the time of patient admission and the time of the
first administration of antimicrobials for MRSA decolonization
were recorded.
As Figure 2 displays, the time from admission to first
administration of MRSA-decolonizing antimicrobial therapy was
found to be in significant decline over the period of the study
(P < 0.001). The coefficient from the model estimates a
reduction in this time of 15.0% per year (95% confidence in-
terval: 11.1e18.7%) over the course of the study. In line with
this, the number of patients who had MRSA-decolonizing anti-
microbial therapy administered within one, two, three, four or
five days of admission increased from 2006 to 2011 (Figure 3).
The percentage of patients treated within one day rose by
22.4% from 17.3% of 179 cases in 2006 to 39.7% of 300 cases in
2011. Conversely, the number of patients whose administration
took more than five days decreased from 41.9% in 2006 to 13.7%
in 2011.
From 2007 to 2008 there was a 7.2% increase in the number
of patients treated within five days: from 61.6% of 164 cases to
68.8% of 144 cases. This coincided with the introduction of
automatic charting of MRSA-decolonizing antimicrobial therapy
and use of the PCR detection method, as well as changes to the
screening procedures and treatment regimens within the hos-
pital. In 2009 it became mandatory for all patients to be
swabbed upon admission, and from 2008 to 2009 a 12.2%nth/year
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Figure 3. Number of days from admission to the administration of MRSA decolonization therapy.
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observed in the number of patients treated within one day of
admission. Finally, from 2009 to 2010, there was a 6.0% in-
crease (from 32.3% of 133 cases to 38.3% of 329 cases) in the
number of patients treated within one day, which coincided
with updates to the Health and Social Care Act 2008 and the
implementation of chromogenic agar for MRSA screening.18Discussion
Across the period of the study, we observed significant re-
ductions in the length of time from admission to administration
of MRSA decolonization antimicrobial therapy. The time
decreased by an average of 15.0% per year, from 4.0 days in
January 2006 to 1.4 days in March 2012. Overall, the number of
patient days, per year, spent waiting for treatment has
decreased substantially from 838 in 2006 to 367 in 2011. As
various national and local interventions related to MRSA pre-
vention occurred in close temporal proximity, it is impossible to
attribute causality to individual factors regarding the observed
reductions. Instead, the increased speed at which MRSA
decolonization antimicrobials are administered following
admission to hospital may be attributed to a number of factors.
These include changes to local infection prevention and control
procedures in response to national policies and improvements
to technology, including the introduction of MRSA-specific
features within the CPOE system in use at this hospital.14,16
In addition to the legal requirement that hospitals must
have systems in place to reduce the prevalence of HCAIs and to
promptly identify those patients with MRSA, the introduction of
MRSA response capabilities into PICS in 2005 was intended to
trigger an institution-wide awareness of the importance of
MRSA decolonization.14 Subsequently, this should have resultedin greater effort to reduce time to treatment in MRSA-
colonized patients and may have led to other infection pre-
vention and control procedures unrelated to the system. For
example, the percentage of patients whose decolonization
antimicrobial therapy was administered within one day of
admission has increased over time (e.g. 17.3% of the 179 pos-
itive MRSA colonizations identified in 2006 were treated within
one day; by 2011 this proportion had risen to 39.7% of the 326
positive cases), whereas the percentage of drugs administered
more than five days after admission has decreased (e.g. 41.9%
in 2006 to 13.7% in 2011).
The automatic charting feature was introduced into our
CPOE system in December 2007, which effectively eliminates
the time that would previously have been taken to raise doc-
tors’ awareness of a positive laboratory result and for them to
prescribe the appropriate decolonizing antimicrobials. This
time-saving may provide some explanation for the 7.2% in-
crease in the number of patients administered decolonization
antimicrobials within five days of admission from 2007 to 2008.
Despite the implementation of automatic charting in December
2007 and the introduction of the faster PCR laboratory method
in January 2008, there was no change in the percentage of
patients administered decolonization antimicrobials within
one day of admission in the first year (20.1% in both years).
Thus, in 2008 automatic charting helped curtail the number of
slowly processed cases (i.e. 5 days from admission to
administration) but did not facilitate an increase in more rapid
administration of decolonization antimicrobials of 2 days
from admission to administration. This may be accounted for
partly by changes to the patient groups who were screened for
MRSA (i.e. critical care patients and admissions from other
hospitals or nursing homes were automatically prescribed MRSA
decolonization therapy upon admission) who would therefore
have been excluded from our data set from January 2008
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introducing the automatic charting feature may have contrib-
uted to the observed decrease in the overall geometric mean
time from admission to administration over this study period.
Furthermore, the mandatory screening of specific patients
upon admission was introduced in 2008, and of all patients
upon admission in 2009. It is interesting that these in-
terventions coincided with further increases in the percentage
of patients administered MRSA decolonization antimicrobial
therapy within one day of admission e from 2008 to 2009 there
was a 12.2% increase and from 2009 to 2010 a further increase
of 6.0%. In 2010, the use of chromogenic agar for MRSA
screening was implemented, which may have contributed to
the greater proportion of screens being processed within one
day. The increase in the absolute number of MRSA screens led
to a need for the microbiology department to process the
swabs more rapidly using the Kiestra laboratory automation
system. Greater efficiency may have contributed to a greater
proportion of swabs being processed on the day of them being
taken. However, it is possible that other factors, such as a
heightened awareness of the importance of MRSA decoloniza-
tion following the publication of governmental reports
(e.g. Health and Social Care Act 2008), also contributed to an
increase in the timeliness of the administration of MRSA-
decolonizing antimicrobials.16
Any CPOE intervention requires both training and rigid
application. All hospital staff required to use PICS receive
formal training, and in this case rigidity was ensured by
mandatory and automatic functions being implemented into
PICS. It may still be possible to produce an incorrect output
through incorrect user interaction, as has been discussed in
previous papers.19,20 We hope that through our system we
minimize the risk of workarounds and variation in related be-
haviours, meaning that the system can effectively perform its
role; in this case reducing the time taken to administer MRSA
antimicrobials.
The average time from admission to administration at the
end of the study period was a little more than one day. Using
current laboratory methods, swabs must be processed over-
night in the laboratory. This means that, unless all laboratory
results are processed on the same day as the patient is
admitted, it may not be possible to reduce the time from
admission to administration much further.
It must be noted that these data were extracted from a
locally developed CPOE system at one NHS hospital and there-
fore may not be generalizable to other institutions, nor where
other systems are in use. Furthermore, as previously stated, we
were unable to utilize data from the few cases of MRSA bac-
teraemia that were presented at the hospital over the study
period, nor compare data from patients’ first hospital admission
to subsequent hospital admissions. It was unfortunate that we
were unable to investigate the statistical significance of indi-
vidual interventions; however, the relative contribution of each
intervention may only be small and lead to an overall significant
decrease in the time taken from admission to administration of
decolonization antimicrobial therapy in MRSA-colonized pa-
tients. Despite the hospital’s policy to isolate patients colonized
with MRSA, we were unable to examine the impact of patient
isolation in this study. It was not possible to quantify retro-
spective data about the rates of MRSA isolation in this hospital,
particularly as the hospital underwent a change in site in May
2011, with which came a change to the availability of single-bedpatient rooms within the hospital. Furthermore, this was a
single-site study and therefore no comparative data were
available. Finally, due to differences in definitions and record
accuracy/completeness, we were unable to compare the time-
liness of administration of MRSA decolonization antimicrobial
therapy via traditional paper-based prescribing (pre-imple-
mentation) with electronic-based prescribing.
Given the potential uses of CPOE and CDS embedded within
these systems in helping to prevent MRSA, future work could
consider the effectiveness of CPOE in improving the rapid
identification and treatment of other multidrug-resistant bac-
teria such as extended-spectrum-producing beta-lactamase
Enterobacteriaceae, or other infections, such as disease caused
byClostridium difficile. Furthermore, it would be interesting to
investigate how CPOE can be used to improve the treatment of
MRSA in different departments separately (e.g. intensive ther-
apy unit, clinical decision unit), as well as investigating staff
perceptions of the use of CPOE in controlling MRSA in hospitals.
In conclusion, it is important to continue to improve the
timeliness of MRSA detection and its treatment. In our hospital,
we observed reductions in the time taken from patient
admission to administration of MRSA decolonization antimi-
crobial therapy. Such reductions may be attributed to a variety
of factors, including national policies and local interventions.
Improvements in information technology within the hospital,
such as the automatic ordering of MRSA decolonization anti-
microbial therapy within our CPOE system, may also help to
improve the timeliness of administration of MRSA-decolonizing
antimicrobials. CPOE with embedded CDS may support other
infection prevention and control methods by improving effi-
ciency in the process from patient admission to administration
of decolonization antimicrobial therapy. Therefore alongside
potential time-savings the opportunity for MRSA to spread is
more limited, whichmay contribute to reducing the prevalence
of MRSA in hospitals and improving patient outcomes.
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